Recently, people around the world have been facing a scary problem: some antibiotics are just not working as they used to, which means infections are getting harder to treat. To talk about this growing issue, three major global bodies, WIPO, WHO, and WTO, got together for a big meeting, opened by WIPO’s Director General Daren Tang. In the WIPO-WHO-WTO Symposium, they discussed why this problem, called antimicrobial resistance (AMR), is rising so fast. Keep reading to understand what this global meeting was all about, how Intellectual Property Rights (IPR) is connected and also learn more about the latest IP news from India and around the world.
What Is AMR and Why Are Antibiotics Suddenly Not Working?
Before we get into the big global meeting, first, we need to understand what AMR actually is and why everyone’s talking about it. Basically, a lot of antibiotics just aren’t doing their job anymore. According to recent WHO updates, many infections are getting harder to treat because the bacteria have learned to outsmart the medicines meant to stop them. This is happening everywhere, but countries like India are seeing it even more, with tons of everyday infections no longer responding to regular antibiotics. This whole issue, called antimicrobial resistance (AMR), has become such a serious problem that global organisations are now jumping in with urgent discussions, awareness campaigns, and expert sessions. In 2025 alone, there were special AMR awareness events and even a brand-new antibiotic approved specifically to fight drug-resistant infections — showing just how big and urgent this problem really is.
Read Also: WIPO Launches IP Management Clinic in Slovenia – Applications Open for 2026 Program
What Did WIPO, WHO, and WTO Discuss at the Global AMR Symposium?
The WIPO-WHO-WTO Symposium happened on 11 December 2025 in Geneva, Switzerland. It was a hybrid event, so people could join either in person or just hop online from anywhere. WIPO, WHO, and WTO teamed up with experts and policymakers for a full day of talks about the growing problem of antibiotic resistance and how everyone needs to work together to deal with it.
To raise awareness and address this growing health concern, WIPO, WHO, and WTO recently came together for a WIPO-WHO-WTO Symposium focused on antimicrobial resistance (AMR) — the issue where antibiotics and other medicines start losing their power against infections. At the meeting, they talked about how AMR is spreading fast around the world, especially in countries like India, where many common antibiotics are already failing. They also pointed out that we’re not getting enough new medicines because developing antibiotics is expensive and risky. The organisations discussed how intellectual property, such as patents, copyrights, trademarks, trade rules, and global health policies, can work together to boost innovation while still making sure people everywhere can access the treatments they need. They also looked at supply chain problems and the need to strengthen manufacturing so countries don’t run into medicine shortages. Overall, the message from the symposium was clear: AMR is a serious global threat, and tackling it will take teamwork, smarter research, and fair access to medicines for everyone.
Conclusion
The WIPO-WHO-WTO Symposium highlighted just how serious the antibiotic resistance problem has become — and how urgently the world needs to act. With major organisations like WIPO, WHO, and WTO now joining forces, there’s finally a stronger push toward better research, fairer access to medicines, and more reliable supply chains. While the challenge is huge, these coordinated efforts give hope that with the right innovation and global cooperation, we can slow down AMR and protect the effectiveness of lifesaving medicines for the future.
Read Also: NIT Rourkela Develops Affordable AI Social Robot Capable of Human-Like Conversation